Minimally invasive treatment of type 2 diabetes is a surgical method of treating diabetes, also called metabolic surgery, which is not suitable for all patients, and standardized treatment under the guidance of a medical professional can improve the prognosis of diabetes. Obese adults with type 2 diabetes try to take lifestyle and drug therapy, blood sugar is still poor control can consider metabolic surgery. Metabolic surgery can significantly improve glycemic control in obese patients with type 2 diabetes, and some of these patients may achieve “remission”. However, it is not suitable for all patients with type 2 diabetes. Metabolic surgery is contraindicated in patients with type 2 diabetes who have significant pancreatic β-cell failure, patients with contraindications to surgery, patients with a body mass index of 25 kg/m², gestational diabetes, and patients with other specific types of diabetes. Patients with type 2 diabetes mellitus should consult with their physician if they are suitable for metabolic surgery.